GlassScriptPhysician profile
Heong Min Kim
NPI 1831682533
$2,861.53
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,248 · 2020: $1,538 · 2021: $76.17.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $2,360.62 | 2019-2020 | |
| Organogenesis INC. | $174.64 | 2020 | |
| Integra Lifesciences Corporation | $109.80 | 2019 | |
| Stryker Corporation | $39.80 | 2021 | |
| Paragon 28, INC. | $36.75 | 2020 | |
| Arteriocyte Medical Systems, INC. | $36.37 | 2021 | |
| Kci USA, INC. | $23.80 | 2019 | |
| Orthofix Medical, INC. | $22.54 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $18.75 | 2019 | |
| Smith+Nephew, INC. | $14.14 | 2020 | |
| Boston Scientific Corporation | $13.41 | 2019 | |
| Acell, INC. | $10.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heong Min Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.